Back
CASI Pharmaceuticals, Inc. Stock Predictions
AI Powerhouse Raises Price - But Room Remains
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
12
CASI
CASI Pharmaceuticals, Inc.
Last Price:
$0.97
Seasonality Move:
7.26%
7 Day Trial
ALL ACCESS PASS
$
7
Still Time to Get In: RAD Intel at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiCASI Pharmaceuticals, Inc. Stock Forecast
-
Is CASI Pharmaceuticals, Inc. Stock Undervalued?The current CASI Pharmaceuticals, Inc. [CASI] share price is $0.98. The Score for CASI is 12, which is 76% below its historic median score of 50, and infers higher risk than normal.
-
CASI is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
Will CASI Pharmaceuticals, Inc. Stock Go Up Next Year?
Data Unavailable
CASI Pharmaceuticals, Inc. Stock Rating
Data Unavailable
CASI Pharmaceuticals, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
China
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
casipharmaceuticals.com
52-Week Data
52-Week High:
3.97
52-Week Low:
0.93
Prediction Charts
Market Cap:
20.1M
Price in USD:
0.98
Volume:
26.6K
Beta:
1.43
Technical Analysis
SMA50:
1.47
SMA100:
1.68
SMA200:
1.79
52-Wk Change:
-71.39%
Stock Predictions
-
Is CASI Pharmaceuticals, Inc. stock public?Yes, CASI Pharmaceuticals, Inc. is a publicly traded company.
-
What is the CASI Pharmaceuticals, Inc. stock quote today?The CASI Pharmaceuticals, Inc. stock price is 0.98 USD today.
-
How to buy CASI Pharmaceuticals, Inc. stock online?You can buy CASI Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-14 | 1.33 | 1.26 | 1.35 | 1.26 |
| Nov-17 | 1.27 | 1.19 | 1.27 | 1.12 |
| Nov-18 | 1.15 | 1.21 | 1.24 | 1.15 |
| Nov-19 | 1.22 | 1.20 | 1.22 | 1.16 |
| Nov-20 | 1.19 | 1.19 | 1.23 | 1.15 |
| Nov-21 | 1.21 | 1.23 | 1.25 | 1.17 |
| Nov-24 | 1.24 | 1.20 | 1.24 | 1.17 |
| Nov-25 | 1.18 | 1.13 | 1.18 | 1.10 |
| Nov-26 | 1.14 | 1.01 | 1.17 | 1.01 |
| Nov-28 | 1.05 | 1.02 | 1.05 | 1.02 |
| Dec-1 | 1.02 | 0.99 | 1.04 | 0.94 |
| Dec-2 | 0.97 | 0.93 | 1.02 | 0.93 |
| Dec-3 | 0.96 | 0.94 | 1.00 | 0.94 |
| Dec-4 | 0.96 | 0.98 | 0.99 | 0.94 |
CASI Pharmaceuticals, Inc. Earnings
Data Unavailable
CASI Pharmaceuticals, Inc. Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.34 per share, and a decrease next year of $0.00 per share.
* CASI Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.